** Shares of cannabis research firm Cronos Group CRON.TO
down 7.7% to C$1.69
** Co to discontinue providing net revenue forecast and
withdraws previously announced revenue target of $100 mln-$110
mln for 2023
** Says discontinuing net revenue forecast reflects
turbulent market conditions beyond previous expectations
** Co says increasing political unrest and stagnant patient
growth in Israel, exiting U.S. business and competitive activity
in Canada, influenced decision
** Including sessions move, shares have fallen 33.8% YTD
(Reporting by Tanay Dhumal in Bengaluru)
((Tanay.Dhumal@thomsonreuters.com;
Twitter: https://twitter.com/TanayDhumal))